Acute Lower Gastrointestinal Bleeding

Acute Lower Gastrointestinal Bleeding

Lower gastrointestinal bleeding is defined as that arising below the ligament of Treitz, i.e., the small intestine or colon; however, up to 95% of cases arise from the colon.

The severity of lower gastrointestinal bleeding ranges from mild anorectal bleeding to massive, large-volume hemato­chezia. Bright red blood that drips into the bowl after a bowel movement or is mixed with solid brown stool signi­fies mild bleeding, usually from an anorectosigmoid source, and can be evaluated in the outpatient setting. In patients hospitalized with gastrointestinal bleeding, lower tract bleeding is one-third as common as upper gastroin­testinal hemorrhage and tends to have a more benign course. Patients hospitalized with lower gastrointestinal tract bleeding are less likely to present with shock or ortho­stasis (less than 20%) or to require transfusions (less than 40%). Spontaneous cessation of bleeding occurs in over 75% of cases, and hospital mortality is less than 4%.


The cause of these lesions depends on both the age of the patient and the severity of the bleeding. In patients under 50 years of age, the most common causes are infectious colitis, anorectal disease, and inflammatory bowel disease. In older patients, significant hematochezia is most often seen with diverticulosis, angioectasias, malignancy, or ischemia. There is an increased risk of lower gastrointesti­nal bleeding in patients taking aspirin, nonaspirin anti­platelet agents, and NSAIDs.


Diverticulosis: Hemorrhage occurs in 3–5% of all patients with diverticu­losis and is the most common cause of major lower tract bleeding, accounting for over 50% of cases. Diverticular bleeding usually presents as acute, painless, large-volume maroon or bright red hematochezia in patients over age 50 years. More than 95% of cases require less than 4 units of blood transfusion. Bleeding subsides spontaneously in 80% but may recur in up to 25% of patients.

Angioectasias: Angioectasias (angiodysplasias) occur throughout the upper and lower intestinal tracts and cause painless bleed­ing ranging from melena or hematochezia to occult blood loss. They are responsible for 5% of cases of lower gastro­intestinal bleeding, where they are most often seen in the cecum and ascending colon. They are flat, red lesions (2–10 mm) with ectatic peripheral vessels radiating from a central vessel, and are most common in patients over 70 years and in those with chronic renal failure. Bleeding in younger patients more commonly arises from the small intestine.

Ectasias can be identified in up to 6% of persons over age 60 years, so the mere presence of ectasias does not prove that the lesion is the source of bleeding, since active bleeding is seldom seen.

Neoplasms: Benign polyps and carcinoma are associated with chronic occult blood loss or intermittent anorectal hematochezia. Furthermore, they may cause up to 7% of acute lower gas­trointestinal hemorrhage. After endoscopic removal of colonic polyps, important bleeding may occur up to 2 weeks later in 0.3% of patients. In general, prompt colonoscopy is recommended to treat postpolypectomy hemorrhage and minimize the need for transfusions.

Inflammatory Bowel Disease: Patients with inflammatory bowel disease (especially ulcer­ative colitis) often have diarrhea with variable amounts of hematochezia. Bleeding varies from occult blood loss to recurrent hematochezia usually mixed with stool. Symp­toms of abdominal pain, tenesmus, and urgency are often present.

Anorectal Disease: Anorectal disease (hemorrhoids, fissures) usually results in small amounts of bright red blood noted on the toilet paper, streaking of the stool, or dripping into the toilet bowl; clinically significant blood loss can sometimes occur. Hemorrhoids are the source in 10% of patients admitted with lower bleeding. Rectal ulcers may account for up to 8% of lower bleeding, usually in elderly or debilitated patients with constipation.

Ischemic Colitis: This condition is seen commonly in older patients, most of whom have atherosclerotic disease. Most cases occur spontaneously due to transient episodes of nonocclusive ischemia. Ischemic colitis may also occur in 5% of patients after surgery for ileoaortic or abdominal aortic aneurysm. In younger patients, colonic ischemia may develop due to vasculitis, coagulation disorders, estrogen therapy, and long-distance running. Ischemic colitis results in hematochezia or bloody diarrhea associated with mild cramps. In most patients, the bleeding is mild and self-limited.

European Society of Gastrointestinal Endoscopy (ESGE) Approach Guideline

  1. ESGE recommends that the initial assessment of patients presenting with acute lower gastrointestinal bleeding should include: a history of co-morbidities and medications that promote bleeding; hemodynamic parameters; physical examination (including digital rectal examination); and laboratory markers. A risk score can be used to aid, but should not replace, clinician judgment.
  2. ESGE recommends that, in patients presenting with a selflimited bleed and no adverse clinical features, an Oakland score of ≤ 8 points can be used to guide the clinician decision to discharge the patient for outpatient investigation.
  3. ESGE recommends, in hemodynamically stable patients with acute lower gastrointestinal bleeding and no history of cardiovascular disease, a restrictive red blood cell transfusion strategy, with a hemoglobin threshold of ≤7g/dL prompting red blood cell transfusion. A post-transfusion target hemoglobin concentration of 7–9g/dL is desirable.
  4. ESGE recommends, in hemodynamically stable patients with acute lower gastrointestinal bleeding and a history of acute or chronic cardiovascular disease, a more liberal red blood cell transfusion strategy, with a hemoglobin threshold of ≤ 8 g/dL prompting red blood cell transfusion. A posttransfusion target hemoglobin concentration of ≥ 10 g/dL is desirable.
  5. ESGE recommends that, in patients with major acute lower gastrointestinal bleeding, colonoscopy should be performed sometime during their hospital stay because there is no high-quality evidence that early colonoscopy influences patient outcomes.
  6. Advertisement
  7. ESGE recommends that patients with hemodynamic instability and suspected ongoing bleeding undergo computed tomography angiography before endoscopic or radiologic treatment to locate the site of bleeding.
  8. ESGE recommends withholding vitamin K antagonists in patients with major lower gastrointestinal bleeding and correcting their coagulopathy according to the severity of bleeding and their thrombotic risk. In patients with hemodynamic instability, we recommend administering intravenous vitamin K and four-factor prothrombin complex concentrate (PCC), or fresh frozen plasma if PCC is not available.
  9. ESGE recommends temporarily withholding direct oral anticoagulants at presentation in patients with major lower gastrointestinal bleeding.
  10. ESGE does not recommend withholding aspirin in patients taking low dose aspirin for secondary cardiovascular prevention. If withheld, low dose aspirin should be resumed, preferably within 5 days or even earlier if hemostasis is achieved or there is no further evidence of bleeding.
  11. ESGE does not recommend routinely discontinuing dual antiplatelet therapy (low dose aspirin and a P2Y12 receptor antagonist) before cardiology consultation. Continuation of the aspirin is recommended, whereas the P2Y12 receptor antagonist can be continued or temporarily interrupted according to the severity of bleeding and the ischemic risk. If interrupted, the P2Y12 receptor antagonist should be restarted within 5 days, if still indicated.


Leave a Reply

%d bloggers like this: